On the other hand, inflammasome activation enhances the tumorilytic activity of CD8+ T cells and NK cells in an IL-18-dependent manner, and further promotes anti-tumor immunity through pyroptosis, an immunogenic cell death that activates antigen-presenting cells through the release of tumor antigens and adjuvants in the TME. The gene discussed is CD8A; the disease is neoplasm.